A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis
- Pankit Vachhani
- , Peter Tan
- , Anne Marie Watson
- , Wu Shang-Ju
- , Ross Baker
- , Stanley Cheung
- , Sung Eun Lee
- , Chih Cheng Chen
- , Tsai Yun Chen
- , Hui Hua Hsiao
- , Jae Hoon Lee
- , Lucia Masarova
- , Shuh Ying Tan
- , Jana Baskar
- , Brett Charlton
- , Alison Findlay
- , Dieter Hamprecht
- , Wolfgang Jarolimek
- , Joanna Leadbetter
- , John Miller
- University of Alabama at Birmingham
- One Clinical Research Pty Ltd
- Liverpool Hospital
- National Taiwan University
- Murdoch University
- ICON Cancer Care
- Chang Gung Memorial Hospital
- National Cheng Kung University
- Kaohsiung Medical University
- Gachon University
- University of Texas MD Anderson Cancer Center
- St. Vincent's Hospital Melbourne
- Syntara Limited
- Massachusetts General Hospital
Research output: Contribution to journal › Article › peer-review